First, let me reiterate that we’re talking about not just the identity of Teva’s manufacturer, but rather the identity of the company* who developed Teva’s version of Lovenox. This consequential distinction may have been lost on some readers of this board.
I did promise not to reveal the identity of Teva’s Lovenox developer while it is not yet in the public domain, but I think those days are numbered. With what’s been said on this board and a few educated guesses, the answer ought to be within reach of someone with a modicum of sleuthing ability.
*It’s a company, not a research institute like Weizmann. Sorry, jbog.